Rachel M. Bartash
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 4
- Clostridium difficile and Clostridium perfringens research 4
-
- Antibiotic Use and Resistance 6
- Co-authors
- Enver Akalin (3 shared papers)Pablo del Valle Loarte (3 shared papers)Yorg Azzi (2 shared papers)Joseph R. Scalea (1 shared paper)Priya Nori (12 shared papers)Maria Ajaimy (2 shared papers)Luz E. Liriano-Ward (2 shared papers)Cindy T. Pynadath (2 shared papers)
- Journals
- Open Forum Infectious Diseases (9 papers)Blood (2 papers)Transplantation and Cellular Therapy (2 papers)Lung (1 paper)International Journal of Antimicrobial Agents (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Rachel M. Bartash
35 papers receiving 1.6k citations
Rachel M. Bartash's Hit Papers
Peers
Comparison fields: 5 of 104
- Applied Microbiology and Biotechnology 202
- Infectious Diseases 933
- Obstetrics and Gynecology 205
- Transplantation 55
- Neurology 246
Countries citing papers authored by Rachel M. Bartash
This map shows the geographic impact of Rachel M. Bartash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Bartash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Bartash more than expected).
Fields of papers citing papers by Rachel M. Bartash
This network shows the impact of papers produced by Rachel M. Bartash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Bartash. The network helps show where Rachel M. Bartash may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel M. Bartash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Covid-19 and Kidney Transplantation Hit paper breakdown → | 2020 | 595 |
| 2 | 2020 | 228 | |
| 3 | 2020 | 225 | |
| 4 | 2020 | 96 | |
| 5 | 2020 | 68 | |
| 6 | 2021 | 66 | |
| 7 | 2003 | 60 | |
| 8 | 2021 | 51 | |
| 9 | 2021 | 35 | |
| 10 | 2017 | 30 | |
| 11 | 2019 | 26 | |
| 12 | 2020 | 23 | |
| 13 | 2017 | 16 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2022 | 9 | |
| 17 | 2020 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2019 | 3 |
About Rachel M. Bartash
Rachel M. Bartash is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Oncology, Molecular Medicine and Clinical Biochemistry, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers), CAR-T cell therapy research (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Neutropenia and Cancer Infections (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (202 citations), Infectious Diseases (933 citations), Obstetrics and Gynecology (205 citations), Transplantation (55 citations) and Neurology (246 citations). Rachel M. Bartash has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Enver Akalin, Pablo del Valle Loarte, Yorg Azzi, Joseph R. Scalea, Priya Nori, Maria Ajaimy, Luz E. Liriano-Ward, Cindy T. Pynadath, Jay A. Graham and Michael Parides. Their work appears in journals such as Open Forum Infectious Diseases, Blood, Transplantation and Cellular Therapy, Lung and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.